Atlas Trials

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.

Clinical trial NCT04920422 · COMPLETED

Trial details

NCT number
NCT04920422
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Colorectal Cancer
Start date
2021-07-15
Primary completion
2022-10-07
Enrollment
242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.